Strategies that inhibit the immune checkpoint blockade (ICB) and reactivate T cells using monoclonal antibodies against programmed cell death protein 1 (PD1) and PD1 ligand 1 (PDL1) have been used to successfully treat immunogenic tumours, and recent efforts have focused on combining this approach with

中文翻译：

---

癌症免疫疗法：T细胞可乘

使用针对程序性细胞死亡蛋白1（PD1）和PD1配体1（PDL1）的单克隆抗体抑制免疫检查点阻断（ICB）并重新激活T细胞的策略已成功用于治疗免疫原性肿瘤，最近的研究集中在将其结合与...接近